Clinical Trials Logo

Initial Insomnia clinical trials

View clinical trials related to Initial Insomnia.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02333149 Withdrawn - Clinical trials for Attention Deficit/Hyperactivity Disorder

Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population

MYNAP
Start date: January 1, 2019
Phase: Phase 3
Study type: Interventional

This study is a multi-center, randomized, triple-blind, placebo-controlled parallel-group trial, in which each participant is offered an N-of-1 trial. The purpose of this study is to assess the efficacy and safety of melatonin (3 mg or 6 mg) compared with placebo for initial insomnia in children with attention-deficit disorder.